Projects per year
Personal profile
About
Dr. Taval's initial interest in teaching started during his training towards obtaining a PhD degree. Upon entering the Ph.D program, the most influential of his mentors were those who successfully achieved a career by combining teaching with research. As a graduate student, Dr. Taval learned to appreciate the aspects of teaching and research that an academic career could provide. In addition to teaching, he has also been involved in mentoring and supervising many work-study students, research assistants and postdoctoral fellows.
Related documents
Education/Academic qualification
Biochemistry, PhD, University of Mysore
… → 2004
Biochemistry, MS, University of Mysore
… → 1996
BS, University of Mysore
… → 1994
External positions
Adjunct Faculty, Emory University
Disciplines
- Pharmacy and Pharmaceutical Sciences
Projects
- 4 Finished
-
Attenuation of immune-complex mediated inflammation through inhibition of NFkb activation by caffeic acid phenethyl ester (CAPE)
1/1/13 → 1/1/15
Project: Research project
-
Synergistic effect of immune-complex and TLR ligand during immune-complex mediated disorders
1/1/12 → 1/1/13
Project: Research project
-
Attenuation of antibody- mediated inflammation by prostaglandin E2 receptor antagonists during autoimmune arthritis
1/1/12 → 1/1/14
Project: Research project
-
Blocking of immune-complex mediated vasculitis using recombinant Fc receptors
1/1/11 → 1/1/15
Project: Research project
-
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro.
Lewis, D. S. M., Ho, J., Wills, S., Kawall, A., Sharma, A., Chavada, K., Ebert, M. C. C. J. C., Evoli, S., Singh, A., Rayalam, S., Mody, V. & Taval, S., Feb 9 2022, In: Scientific Reports. 12Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Barbaloin (Aloin-A) and isobarbaloin (Aloin-B) selectively inhibit activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
Lewis, D. S., Chavada, K., Ho, J., Wills, S., Rayalam, S., Mody, V. & Taval, S., May 3 2022.Research output: Contribution to conference › Presentation
Open AccessFile -
Development of inhaled PLGA encapsulated Ivermectin for the treatment of SARS-CoV-2
Sood, S., Mody, V., Rayalam, S., Taval, S. & Jha, S., May 3 2022.Research output: Contribution to conference › Presentation
-
Identification of phytochemicals that inhibit the enzymatic activity of SARS-CoV-2 3-chymotrypsin like protease (3CLpro) in vitro.
Sharma, A., Kawall, A., Lewis, D., Chavada, K., Taval, S., Mody, V. & Rayalam, S., May 3 2022.Research output: Contribution to conference › Presentation
Open AccessFile -
Inhibitory effect of caffeic acid phenethyl ester (CAPE) derivatives on human multiple myeloma cell growth
Staskiewicz, A., Fields, T., Dang, T., Rayalam, S. & Taval, S., May 3 2022.Research output: Contribution to conference › Presentation
Activities
- 3 Membership of network
-
American College of Clinical Pharmacy (External organization)
Shashidharamurthy Taval (Member)
Jan 1 2012 → …Activity: Membership › Membership of network
-
American Association for the Advancement of Science (External organization)
Shashidharamurthy Taval (Member)
Jan 1 2005 → Jan 1 2010Activity: Membership › Membership of network
-
American Association of Immunologist (External organization)
Shashidharamurthy Taval (Member)
Jan 1 2005 → …Activity: Membership › Membership of network
Prizes
-
American Association of Immunologist Trainee Awards. 2011
Taval, Shashidharamurthy (Recipient), 2011
Prize: Prize (including medals and awards)
-
Early Career Faculty Travel Award, American Association of Immunologists, 2011
Taval, Shashidharamurthy (Recipient), 2011
Prize: Prize (including medals and awards)
-
Scientist Development Grant Program Award, American Heart Association, 2011
Taval, Shashidharamurthy (Recipient), 2011
Prize: Prize (including medals and awards)